Medicover Genetics at ESHRE 2025 in Paris

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

Another year of ESHRE, another step forward in reproductive innovation

From June 29 to July 2, the Medicover Genetics team proudly participated in the at the Paris Expo Porte de Versailles. Despite the summer heatwave outside, the congress hall was buzzing with even greater energy, welcoming over 12,000 attendees and more than 200 exhibitors from across the globe, all united by a common goal: advancing reproductive science and innovation.

Integrated fertility care at booth D026

At the heart of our participation was Booth D026, where Medicover Genetics exhibited alongside partners from the broader Medicover Group, (Denmark) and (Ukraine). This joint presence showcased our full-circle approach to reproductive health, offering integrated solutions that span the entire fertility journey: from gamete donation to genetic diagnostics, infertility screening, and prenatal care.

The booth served as a vibrant hub for meaningful conversations with clinicians, researchers, and fertility experts. Visitors explored a comprehensive portfolio of innovative reproductive health solutions, including:

  • for genetic conditions
  • Comprehensive endometrial microbiome analysis ()

Each solution is designed to deliver clinically actionable insights, enabling personalized care, improving diagnostic precision, and enhancing IVF success rates. Our presence at ESHRE reaffirmed Medicover Genetics’ commitment to providing science-driven, data-powered tools that support both patients and professionals in reproductive medicine.

We extend our heartfelt thanks to all our colleagues, partners, and peers who made ESHRE 2025 a productive and inspiring experience. As we continue to expand our services in genetic testing and fertility care, we remain dedicated to shaping the future of reproductive health through innovation, collaboration, and clinical excellence.

About ESHRE

promotes research, education, and the advancement of clinical practices in human reproduction and embryology. Its annual congress is one of the world’s largest and most influential gatherings in the fields of fertility, reproductive biology, and assisted conception, bringing together global leaders to share progress and shape the future of care.

Last updated: October 7, 2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases

  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- and CLIA- and ISO15189 accredited, GMP- and ISO9001 and 13485 certified

Are you a patient?

Are you a physician?